Sep 8, 2008 7:46 AM ET | Site Changes | Help
Results 1 - 10 of 802 : 1 2 3 4 5 6 7 8 9 Next
The medical-device maker is buying Abbott's spine business.
Why Pfizer Made an Interesting Blockbuster Bet
Pfizer inks a rich deal to get a late-stage-drug candidate.
4-Star Stocks Poised to Pop: Merck
Market-trouncing returns could be written in these four stars.
Monsanto's Public-Relations Nightmare
The agriculture giant has to defend its patents without looking like it's picking on the little guy.
4-Star Stocks Poised to Pop: GameStop
Market-trouncing returns could be written in this 4-Star.
Supercharge Your Income With These Stocks
Dividend stocks offer the best option, but you need to start now.
4-Star Stocks Poised to Pop: Amgen
Market-trouncing returns could be written in this 4-Star.
Stent Makers Getting Desperate
When competition increases, a company's got to do something.
Top-Rated Stocks That Get Low Grades
These high-flying investments keep shareholders on a short leash
Fool Blog: Stocks We'd Recommend to Our Grandmas
What makes the cut?
Legal Information © 1995 - 2008 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK